pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
pociredir
Sickle Cell Disease
$FULC
Fulcrum Therapeutics, Inc.
0
catalysts
Phase 2
podentamig
podentamig [INN]
Refractory Multiple Myeloma
$MRK
Merck & Co., Inc.
0
catalysts
Phase 2
polzastobart
Cutaneous Squamous Cell Carcinoma (cSCC)
Concentra Biosciences LLC
0
catalysts
Phase 2
← prev
page 44 of 50
next →
131
Pain
89
Neurology
1
povidone iodine ER
povidone iodine [USP]
Bacterial Conjunctivitis
iView Therapeutics Inc
0
catalysts
Phase 2
prabotulinumtoxin A
Spasmodic Torticollis (Cervical Dystonia)
Synaptosomal-associated protein 25
$AEON
AEON Biopharma, Inc.
0
catalysts
Phase 2
praliciguat
Focal Segmental Glomerulosclerosis (FSGS)
Soluble guanylate cyclase
$AKBA
Akebia Therapeutics, Inc.
0
catalysts
Phase 2
pravibismane
pravibismane [INN]
Diabetic Foot Infection (DFI)
Microbion Corp
0
catalysts
Phase 2
prexasertib mesylate monohydrate
Endometrial Cancer
$ACRV
Acrivon Therapeutics, Inc.
0
catalysts
Phase 2
prexigebersen
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Growth factor receptor-bound protein 2 mRNA
$BPTH
BIO-PATH HOLDINGS, INC.
0
catalysts
Phase 2
privosegtor
privosegtor [INN]
Non-Arteritic Anterior Ischemic Optic Neuropathy
$OCS
Oculis Holding AG
0
catalysts
Phase 2
prizloncabtagene autoleucel
prizloncabtagene autoleucel [INN]
Diffuse Large B-Cell Lymphoma
Janssen Biotech Inc
0
catalysts
Phase 2
progerinin
Hutchinson-Gilford Progeria
PRG S&Tech Inc
0
catalysts
Phase 2
pyrilutamide
Androgenic Alopecia
Kintor Pharmaceutical Ltd
0
catalysts
Phase 2
quaratusugene ozeplasmid
Reqorsa (quaratusugene ozeplasmid)
Non-Small Cell Lung Cancer
$GNPX
Genprex, Inc.
0
catalysts
Phase 2
rF1V Vaccine
Plague
U.S. Army Medical Research Institute of Infectious Diseases
0
catalysts
Phase 2
rademikibart
rademikibart [INN]
Acute Asthma
Suzhou Connect Biopharmaceuticals Ltd
0
catalysts
Phase 2
radgocitabine
radgocitabine [INN]
Refractory Acute Myeloid Leukemia
Delta-Fly Pharma Inc
0
catalysts
Phase 2
raguneprocel
raguneprocel [INN]
Parkinson's Disease
Sumitomo Chemical Co Ltd
0
catalysts
Phase 2
ranpirnase
Onconase (ranpirnase)
Genital Warts (Condylomata Acuminata)
Okogen Inc
0
catalysts
Phase 2
refisolone
Salubrin-HF (refisolone)
Premenstrual Dysphoric Disorder (PMDD)
$VTGN
Vistagen Therapeutics, Inc.
0
catalysts
Phase 2
regdanvimab
regdanvimab [INN]
Coronavirus Disease 2019 (COVID-19)
Celltrion Inc
0
catalysts
Phase 2
relatlimab
Metastatic Hepatocellular Carcinoma (HCC)
Lymphocyte activation gene 3 protein
Bristol-Myers Squibb Co
0
catalysts
Phase 2
remetinostat
Cutaneous T-Cell Lymphoma
Biossil Inc
0
catalysts
Phase 2
rencofilstat
Hepatocellular Carcinoma
$HEPA
Hepion Pharmaceuticals, Inc.
0
catalysts
Phase 2
rentosertib acetate
Idiopathic Pulmonary Fibrosis
InSilico Medicine
0
catalysts
Phase 2
resiquimod
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Toll-like receptor 7
Toll-like receptor 8
SURGE Therapeutics Inc
0
catalysts
Phase 2
resiquimod sulfate
Squamous Non-Small Cell Lung Cancer
$EIKN
Eikon Therapeutics, Inc.
0
catalysts
Phase 2
resomelagon acetate
Rheumatoid Arthritis
SynAct Pharma AB
0
catalysts
Phase 2
respiratory syncytial virus vaccine
mRESVIA
Respiratory Syncytial Virus (RSV) Infections
Fusion glycoprotein F0
$MRNA
Moderna, Inc.
0
catalysts
Phase 2
rezatapopt
Bile Duct Cancer (Cholangiocarcinoma)
$PMVP
PMV Pharmaceuticals, Inc.
0
catalysts
